Osteocrin ameliorates adriamycin nephropathy via p38 mitogen-activated protein kinase inhibition.
Handa T, Mori KP, Ishii A, Ohno S, Kanai Y, Watanabe-Takano H, Yasoda A, Kuwabara T, Takahashi N, Mochizuki N, et al. Sci Rep. 2021 Nov 8; 11(1):21835. Epub 2021 Nov 8.